FDA Inspection
Aparna Kalyan, M.D.Aparna Kalyan, M.D. – FDA Inspection, Feb 18, 2025
Record Details
This FDA Inspection record concerns Aparna Kalyan, M.D., with an inspection on February 18, 2025, issued by the Chicago District Office, covering human drugs.
- Office
- Chicago District Office
View Company Profile
ID · da4ea4b9-d098-4973-8880-7c78bb804bf3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1261875
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring: Human Drugs
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.